Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, ...

On Wednesday, Sigachi Industries Ltd. made its Q2FY25 and H1FY25 announcements. When compared to Q2FY24, when net revenues ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.2, along ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

Q2 Results Review: 66% of companies reported EPS downgrades for FY25. Among these, 40% saw EPS reductions exceeding 3%, 29% ...

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

For Q2, the company’s revenue from the Indian market rose 13.9 per cent to Rs 1,281.7 crore, contributing 37 per cent to ...